Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shim

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 2, 2015
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancerS H Lim, M Hong, S Ahn, et al.
British Journal of Cancer|June 27, 2007
A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future managementH-S Lee, S T Kim, J Lee, et al.
Scientific Reports|June 8, 2022
Substrate-dependent modulation of the leukotriene A<sub>4</sub> hydrolase aminopeptidase activity and effect in a murine model of acute lung inflammationKyung Hyeon Lee, Nadia Fazal Ali, Soo Hyeon Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2013
Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancerY H Yun, E-J Shon, A-J Yang, et al.
ESMO Open|February 14, 2022
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II studyS Park, J-M Sun, Y-L Choi, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2001
Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancerY C Ahn, K Park, D Y Kim, et al.
American Journal of Clinical Oncology|June 11, 1999
Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junctionB Y Ryoo, Y K Kang, Y H Im, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
A protective role for B-1 cells and oxidation-specific epitope IgM in lung fibrosisJeffrey M Sturek, Riley T Hannan, Aditi Upadhye, et al.
Biomedicines|June 28, 2023
Hyperpolarized Xenon-129: A New Tool to Assess Pulmonary Physiology in Patients with Pulmonary FibrosisKun Qing, Talissa A Altes, John P Mugler, et al.
Histopathology|February 28, 2023
Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinomaTae H Hong, Soohyun Hwang, Yoon-La Choi, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|December 2, 2015
Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancerS H Lim, M Hong, S Ahn, et al.
British Journal of Cancer|June 27, 2007
A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future managementH-S Lee, S T Kim, J Lee, et al.
Scientific Reports|June 8, 2022
Substrate-dependent modulation of the leukotriene A<sub>4</sub> hydrolase aminopeptidase activity and effect in a murine model of acute lung inflammationKyung Hyeon Lee, Nadia Fazal Ali, Soo Hyeon Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2013
Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancerY H Yun, E-J Shon, A-J Yang, et al.
ESMO Open|February 14, 2022
Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II studyS Park, J-M Sun, Y-L Choi, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2001
Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancerY C Ahn, K Park, D Y Kim, et al.
American Journal of Clinical Oncology|June 11, 1999
Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junctionB Y Ryoo, Y K Kang, Y H Im, et al.
Biorxiv : the Preprint Server for Biology|April 25, 2024
A protective role for B-1 cells and oxidation-specific epitope IgM in lung fibrosisJeffrey M Sturek, Riley T Hannan, Aditi Upadhye, et al.
Biomedicines|June 28, 2023
Hyperpolarized Xenon-129: A New Tool to Assess Pulmonary Physiology in Patients with Pulmonary FibrosisKun Qing, Talissa A Altes, John P Mugler, et al.
Histopathology|February 28, 2023
Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinomaTae H Hong, Soohyun Hwang, Yoon-La Choi, et al.
Pageof 9